Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Qualigen Therapeutics, Inc. (RTTR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/07/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
| 05/02/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 04/29/2022 |
10-K/A
| Annual Report for the period ended December 31, 2021 [amend] |
| 03/31/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 03/31/2021 |
10-KT
| Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]: |
| 04/24/2020 |
10-K/A
| Annual Report for the period ended December 31, 2019 [amend] |
| 03/31/2020 |
10-K
| Annual Report for the period ended December 31, 2019 |
| 04/01/2019 |
10-K
| Annual Report for the period ended December 31, 2018 |
| 03/19/2018 |
10-K
| Annual Report for the period ended December 31, 2017 |
| 02/27/2017 |
10-K
| Annual Report for the period ended December 31, 2016 |
| 03/21/2016 |
10-K
| Annual Report for the period ended December 31, 2015 |
|
|